Immune Peptides Related to Dipeptidyl Aminopeptidase IV/CD26

Handbook of Biologically Active Peptides

Volumn , Issue , 2006, Pages 567-572

  Ansorge, Siegfried ^a   Reinhold, Dirk ^b  

^a Zenit Building ^*  (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 42549107605     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012369442-3/50084-2     Document Type: Chapter

References (38)

1. Bank U, Tadje J, Helmuth M, Stefin S, Täger M, Wolke C, et al. Dipeptidyl peptidase IV and Alanyl-Aminopeptidases as a new target complex for treatment of autoimmune and inflammatory diseases-proof concept in a mouse of colitis. Adv Exp Med Biol 2006, 575:181-193.
2. Cohen M, Fruitier-Arnaudin I, Piot JM Hemorphins: substrates and/or inhibitors of dipeptidyl peptidase IV. Hemorphins N-terminus sequence influence on the interaction between hemorphins and DPPIV. Biochimie 2004, 86:31-37.
3. De La Luz Sierra M, Yang F, Narazaki M, Salvucci O, Davis D, Yarchoan R, et al. Differential processing of stromal-derived factor-1alpha and stromal-derived factor-1beta explains functional diversity. Blood 2004, 103:2452-2459.
4. Delgado M, Abad C, Martinez C, Juarranz MG, Leceta J, Ganea D, et al. PACAP in immunity and inflammation. Ann NY Acad Sci 2003, 992:141-157.
5. De Meester I, Korom S, Van Damme J, Scharpe S CD26, let it cut or cut it down. Immunol Today 1999, 20:367-375.
6. De Meester I, Lambeir AM, Proost P, Scharpe S Dipeptidyl peptidase IV substrates. An update on in vitro peptide hydrolysis by human DPPIV. Adv Exp Med Biol 2003, 524:3-17.
7. Dimitrijevic M, Stanojevic S, Vujic V, Kovacevic-Jovanovic V, Beck-Sickinger A, Demuth H, et al. Effect of neuropeptide Y on inflammatory paw edema in the rat: involvement of peripheral NPY Y1 and Y5 receptors and interaction with dipeptidylpeptidase IV (CD26). J Neuroimmunol 2002, 129:35-42.
8. Evans DM Dipeptidyl peptidase IV inhibitors. I Drugs 2002, 5:577-585.
9. Florianczyk B Structure and diagnostic value of procalcitonin. Ann Univ Mariae Curie Sklodowska 2003, 58:338-342.
10. Forssmann U, Kruschinski C, Eschner S, Skripuletz T, Stephan M, Forsmann WG, et al. Dipeptidylpeptidase IV modulates CCL11/Eotaxin-induced recruitment of eosinophiles. Adv Exp Med Biol 2006, (in press).
11. Gorrell MD Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders. Clin Sci 2005, 108:277-292.
12. Grimsholm O, Rantapaa-Dahlqvist S, Forsgren S Levels of gastrin-releasing peptide and substance P in synovial fluid and serum correlate with levels of cytokines in rheumatoid arthritis. Arthritis Res Ther 2005, 7:R416-R426.
13. Hoffmann T, Faust J, Neubert K, Ansorge S Dipeptidyl peptidase IV (CD 26) and aminopeptidase N (CD 13) catalyzed hydrolysis of cytokines and peptides with N-terminal cytokined sequences. FEBS Lett 1993, 336:61-64.
14. Kähne T, Lendeckel U, Wrenger S, Neubert K, Ansorge S, Reinhold D Dipeptidyl peptidase IV: a cell surface peptidase involved in regulating T cell growth (review). Int J Mol Med 1999, 4:3-15.
15. Korom S, De Meester I, Stadlbauer TH, Chandraker A, Schaub M, Sayegh MH, et al. Inhibition of CD26/dipeptidyl peptidase IV activity in vivo prolongs cardiac allograft survival in rat recipients. Transplantation 1997, 63:1495-1500.
16. Kubota T, Flentke GR, Bachovchin WW, Stollar BD Involvement of dipeptidyl peptidase IV in an in vivo immune response. Clin Exp Immunol 1992, 89:192-197.
17. Lambier AM, Durinx C, Proost P, Van Damme J, Scharpe S, De Meester I Kinetic study of the processing by dipeptidyl-peptidase IV/CD 26 of neuropeptides involved in pancreatic insulin secretion. FEBS Lett 2001, 507:327-330.
18. Lambeir AM, Proost P, Durinx C, Bal G, Senten K, Augustyns K, et al. Kinetic investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family. J Biol Chem 2001, 276:29839-29845.
19. Lambeir AM, Durinx C, Scharpe S, De Meester I Dipeptidylpeptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV. Crit Rev Clin Lab Sci 2003, 40:209-294.
20. Mentlein R, Dahms P, Grandt D, Krüger R Proteolytic processing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV. Regul Pept 1993, 49:133-144.
21. Mentlein R Cell-surface peptidases. Int Rev Cytol 2004, 235:165-213.
22. Nausch I, Heymann E Substance P in human plasma is degraded by dipeptidyl peptidase IV, not by cholinesterase. J Neurochem 1985, 44:1354-1357.
23. Nausch I, Mentlein R, Heymann E The degradation of bioactive peptides and proteins by dipeptidyl peptidase IV from human placenta. Biol Chem Hoppe Seyler 1990, 371:1113-1118.
24. O'Connor TM, O'Connell J, O'Brien DI, Goode T, Bredin CP, Shanahan F The role of substance P in inflammatory disease. J Cell Physiol 2004, 201:167-180.
25. Pozo D, Delgado M The many faces of VIP in neuroimmunology: a cytokine rather a neuropeptide?. FASEB J 2004, 18:1325-1334.
26. Qi SY, Riviere PJ, Trojnar J, Junien JL, Akinsanya KO Cloning and characterization of dipeptidyl peptidase 10, a new member of an emerging subgroup of serine proteases. Biochem J 2003, 373:179-189.
27. Reinhold D, Hemmer B, Gran B, Born I, Faust J, Neubert K, McFarland HF, et al. Inhibitors of dipeptidyl peptidase IV/CD26 suppress activation of human MBP-specific CD4+T cell clones. J Neuroimmunol 1998, 87:203-209.
28. Riemann D, Hansen GH, Niels-Christiansen L, Thorsen E, Immerdal L, Santos AN, et al. Caveolae/lipid rafts in fibroblast-like synoviocytes: ectopeptidase-rich membrane microdomains. Biochem J 2001, 354:47-55.
29. Schön E, Mansfeld HW, Demuth HU, Barth A, Ansorge S The dipeptidyl peptidase IV, a membrane enzyme involved in the proliferation of T lymphocytes. Biomed Biochim Acta 1985, 44:K9-K15.
30. Schön E, Born I, Demuth HU, Faust J, Neubert K, Steinmetzer T, et al. Dipeptidyl peptidase IV in the immune system. Effects of specific enzyme inhibitors on activity of dipeptidyl peptidase IV and proliferation of human lymphocytes. Biol Chem Hoppe Seyler 1991, 372:305-311.
31. Sedo A, Malik R Dipeptidyl peptidase IV-like molecules: homologous proteins or homologous activities. Biochim Biophys Acta 2001, 1550:107-116.
32. Steinbrecher A, Reinhold D, Quigley L, Gado A, Tresser N, Izikson L, et al. Targeting dipeptidyl peptidase IV (CD26) suppresses autoimmune encephalomyelitis and up-regulates TGF-beta 1 secretion in vivo. J Immunol 2001, 166:2041-2048.
33. Tanaka S, Murakami T, Horikawa H, Sugiura M, Kawashima K, Sugita T Suppression of arthritis by the inhibitors of dipeptidyl peptidase IV. Int J Immunopharmacol 1997, 19:15-24.
34. Tanaka S, Murakami T, Nonaka N, Ohnuki T, Yamada M, Sugita T Anti-arthritic effects of the novel dipeptidyl peptidase IV inhibitors TMC-2A and TSL-225. Immuno-pharmacology 1998, 40:21-26.
35. Umezawa H, Aoyagi T, Ogawa K, Naganawa H, Hamada M, Takeuchi T Diprotins A and B, inhibitors of dipeptidyl aminopeptidase IV, produced by bacteria. J Antibiot 1984, 37:422-425.
36. Weber AE Dipeptidyl peptidase IV inhibitors for the treatment of diabetes. J Med Chem 2004, 47:4135-4141.
37. Wrenger S, Kähne T, Bohuon C, Weglöhner W, Ansorge S, Reinhold D Amino-terminal truncation of procalcitonin, a marker for systemic bacterial infections, by dipeptidyl peptidase IV (DP IV). FEBS Lett 2000, 466:155-159.
38. Wrenger S, Faust J, Mrestani-Klaus C, Fengler A, Stöckel-Maschek A, Lorey S, et al. Down-regulation of T cell activation following inhibition of dipeptidyl peptidase IV/CD26 by the N-terminal part of the thromboxane A2 receptor. J Biol Chem 2000, 275:22180-22186.